Cargando…

Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study

AIM: We aimed to compare neuropeptide levels between patients with major psychiatric disorders and healthy controls and examine their association with symptoms and cognitive function. METHODS: The participants were 149 patients with schizophrenia, 115 patients with bipolar disorder (BD), 186 unremit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hidese, Shinsuke, Yoshida, Fuyuko, Ishida, Ikki, Matsuo, Junko, Hattori, Kotaro, Kunugi, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009433/ https://www.ncbi.nlm.nih.gov/pubmed/36414415 http://dx.doi.org/10.1002/npr2.12304

Ejemplares similares

Cerebrospinal Fluid Inflammatory Cytokine Levels in Patients With Major Psychiatric Disorders: A Multiplex Immunoassay Study
por: Hidese, Shinsuke, et al.
Publicado: (2021)

Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study
por: Hidese, Shinsuke, et al.
Publicado: (2020)

Possible associations between plasma fibroblast growth factor 21 levels and cognition in bipolar disorder
por: Omileke, Favour, et al.
Publicado: (2020)

Performance on the Wechsler Adult Intelligence Scale (WAIS) in Japanese patients with bipolar and major depressive disorders in euthymic and depressed states
por: Matsuo, Junko, et al.
Publicado: (2021)

Relationship of Handgrip Strength and Body Mass Index With Cognitive Function in Patients With Schizophrenia
por: Hidese, Shinsuke, et al.
Publicado: (2018)

Association between lower estimated premorbid intelligence quotient and smoking behavior in patients with schizophrenia
por: Hidese, Shinsuke, et al.
Publicado: (2018)

Reduced plasma orexin-A levels in patients with bipolar disorder
por: Tsuchimine, Shoko, et al.
Publicado: (2019)

Sensorimotor Gating in Depressed and Euthymic Patients with Bipolar Disorder: Analysis on Prepulse Inhibition of Acoustic Startle Response Stratified by Gender and State
por: Matsuo, Junko, et al.
Publicado: (2018)

Altered polyunsaturated fatty acid levels in relation to proinflammatory cytokines, fatty acid desaturase genotype, and diet in bipolar disorder
por: Koga, Norie, et al.
Publicado: (2019)

Gut permeability and its clinical relevance in schizophrenia
por: Ishida, Ikki, et al.
Publicado: (2022)

Association of body mass index and its classifications with gray matter volume in individuals with a wide range of body mass index group: A whole-brain magnetic resonance imaging study
por: Hidese, Shinsuke, et al.
Publicado: (2022)

Correlation Between the Wechsler Adult Intelligence Scale- 3(rd) Edition Metrics and Brain Structure in Healthy Individuals: A Whole-Brain Magnetic Resonance Imaging Study
por: Hidese, Shinsuke, et al.
Publicado: (2020)

Corrigendum: Correlation Between the Wechsler Adult Intelligence Scale- 3(rd) Edition Metrics and Brain Structure in Healthy Individuals: A Whole-Brain Magnetic Resonance Imaging Study
por: Hidese, Shinsuke, et al.
Publicado: (2020)

Relationship between Lifetime Suicide Attempts and Schizotypal Traits in Patients with Schizophrenia
por: Teraishi, Toshiya, et al.
Publicado: (2014)

Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial
por: Hidese, Shinsuke, et al.
Publicado: (2019)

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2020)

Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
por: Yu, Hua, et al.
Publicado: (2023)

PT599. Effect of single ketogenic diet containing medium chain triglycerides on cognitive functions in elderly adults
por: Matsuo, Junko, et al.
Publicado: (2016)

Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder
por: Ogawa, Shintaro, et al.
Publicado: (2015)

Examining the source of increased bipolar disorder and major depressive disorder common risk variation burden in multiplex schizophrenia families
por: Ahangari, Mohammad, et al.
Publicado: (2022)

Bifidobacterium and Lactobacillus Counts in the Gut Microbiota of Patients With Bipolar Disorder and Healthy Controls
por: Aizawa, Emiko, et al.
Publicado: (2019)

The common functional FKBP5 variant rs1360780 is associated with altered cognitive function in aged individuals
por: Fujii, Takashi, et al.
Publicado: (2014)

Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Rollins, Brandi, et al.
Publicado: (2009)

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2021)

PS195. Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder
por: Ogawa, Shintaro, et al.
Publicado: (2016)

(13)C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder
por: Teraishi, Toshiya, et al.
Publicado: (2015)

Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder
por: Richards, Alexander L., et al.
Publicado: (2022)

Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder
por: Gotoh, Leo, et al.
Publicado: (2019)

Characterization of Postprandial Effects on CSF Metabolomics: A Pilot Study with Parallel Comparison to Plasma
por: Saito, Kosuke, et al.
Publicado: (2020)

PS46. Distinct and shared morphometric biomarkers of depressed individuals with bipolar disorder and major depressive disorder
por: Matsuo, Koji, et al.
Publicado: (2016)

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder
por: Itagaki, Kei, et al.
Publicado: (2019)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
por: Yang, Yongfeng, et al.
Publicado: (2019)

Neuropeptide y and neuropeptide s in major depressive disorder and post-traumatic stress disorder: Preclinical andclinical studies
por: Mathe, A.
Publicado: (2021)

PS221. Major depressive disorder and initial insulin hyposecretion in oral glucose tolerance test
por: Aizawa, E, et al.
Publicado: (2016)

Effect of Lacticaseibacillus paracasei Strain Shirota on Improvement in Depressive Symptoms, and Its Association with Abundance of Actinobacteria in Gut Microbiota
por: Otaka, Machiko, et al.
Publicado: (2021)

Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning
por: Yang, Qingxia, et al.
Publicado: (2022)

Autistic-Like Traits in Adult Patients with Mood Disorders and Schizophrenia
por: Matsuo, Junko, et al.
Publicado: (2015)

Pareidolia in Schizophrenia and Bipolar Disorder
por: Abo Hamza, Eid G., et al.
Publicado: (2021)

An fMRI Investigation into the Effects of Ketogenic Medium-Chain Triglycerides on Cognitive Function in Elderly Adults: A Pilot Study
por: Yomogida, Yukihito, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kskimap2hqqjsc48k0ksq5gumq